186 related articles for article (PubMed ID: 23392213)
1. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
Bernard V; Lombard-Bohas C; Taquet MC; Caroli-Bosc FX; Ruszniewski P; Niccoli P; Guimbaud R; Chougnet CN; Goichot B; Rohmer V; Borson-Chazot F; Baudin E;
Eur J Endocrinol; 2013 May; 168(5):665-74. PubMed ID: 23392213
[TBL] [Abstract][Full Text] [Related]
2. Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
Asayama M; Yamada-Murano T; Hara H; Ooki A; Kurosumi M; Yamaguchi K
Jpn J Clin Oncol; 2014 Feb; 44(2):186-90. PubMed ID: 24367043
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control in patients with insulinoma treated with everolimus.
Kulke MH; Bergsland EK; Yao JC
N Engl J Med; 2009 Jan; 360(2):195-7. PubMed ID: 19129539
[No Abstract] [Full Text] [Related]
4. The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring.
Yanagiya S; Cho KY; Nakamura A; Nomoto H; Kawamoto Y; Kawakubo K; Komatsu Y; Mitsuhashi T; Miyoshi H; Atsumi T
Intern Med; 2018 Sep; 57(17):2527-2531. PubMed ID: 29877259
[TBL] [Abstract][Full Text] [Related]
5. Pasireotide for malignant insulinoma.
Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
[TBL] [Abstract][Full Text] [Related]
6. Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
Fiebrich HB; Siemerink EJ; Brouwers AH; Links TP; Remkes WS; Hospers GA; de Vries EG
Oncologist; 2011; 16(6):783-7. PubMed ID: 21482586
[TBL] [Abstract][Full Text] [Related]
7. Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report.
Rouf S; Boujtat K; El Harroudi T; Latrech H
Int J Clin Pharmacol Ther; 2024 Jun; 62(6):278-283. PubMed ID: 38431828
[TBL] [Abstract][Full Text] [Related]
8. Treatment: symptomatic treatment of hypoglycaemia.
Tabarin A; Goichot B;
Ann Endocrinol (Paris); 2013 Jul; 74(3):196-9. PubMed ID: 23791453
[No Abstract] [Full Text] [Related]
9. Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
Ong GS; Henley DE; Hurley D; Turner JH; Claringbold PG; Fegan PG
Eur J Endocrinol; 2010 May; 162(5):1001-8. PubMed ID: 20164213
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic options for metastatic malignant insulinomas.
de Herder WW; van Schaik E; Kwekkeboom D; Feelders RA
Clin Endocrinol (Oxf); 2011 Sep; 75(3):277-84. PubMed ID: 21649688
[TBL] [Abstract][Full Text] [Related]
11. Malignant metastatic insulinoma-postoperative treatment and follow-up.
Starke A; Saddig C; Mansfeld L; Koester R; Tschahargane C; Czygan P; Goretzki P
World J Surg; 2005 Jun; 29(6):789-93. PubMed ID: 15880279
[TBL] [Abstract][Full Text] [Related]
12. Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Oziel-Taieb S; Maniry-Quellier J; Chanez B; Poizat F; Ewald J; Niccoli P
Front Endocrinol (Lausanne); 2022; 13():860614. PubMed ID: 35518928
[TBL] [Abstract][Full Text] [Related]
13. Advanced malignant insulinoma. Everolimus response and toxicity.
Cuesta Hernández M; Gómez Hoyos E; Marcuello Foncillas C; Sastre Valera J; Díaz Pérez JÁ
Endocrinol Nutr; 2014 Jan; 61(1):e1-3. PubMed ID: 23999009
[No Abstract] [Full Text] [Related]
14. Nocardia brain abscess in a patient treated with everolimus for a metastatic insulinoma.
Walter T; Zadeh G; Hawryluk G; Krzyzanowska MK
J Clin Oncol; 2013 Feb; 31(6):e73-5. PubMed ID: 23182991
[No Abstract] [Full Text] [Related]
15. Everolimus resolving hypoglycemia, producing hyperglycemia, and necessitating insulin use in a patient with diabetes and nonresectable malignant insulinoma.
Ferrer-García JC; Tolosa-Torréns M; Hernando-Meliá C; Arribas-Palomar L; Sánchez-Juan C
Endocr Pract; 2011; 17(2):e17-20. PubMed ID: 21247848
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Liver-Directed Therapy for the Management of Intractable Hypoglycemia in Metastatic Insulinoma.
Habibollahi P; Bai HX; Sanampudi S; Soulen MC; Dagli M
Pancreas; 2020 Jul; 49(6):763-767. PubMed ID: 32541627
[TBL] [Abstract][Full Text] [Related]
17. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
Hoff AO; Vassilopoulou-Sellin R
Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
[TBL] [Abstract][Full Text] [Related]
18. Long-term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia.
Thomas NJ; Brooke AM; Besser GM
Clin Endocrinol (Oxf); 2013 May; 78(5):799-800. PubMed ID: 23082777
[No Abstract] [Full Text] [Related]
19. Recurrence of Metastatic Pro-insulinoma Nearly 50 Years After Subtotal Pancreatectomy.
Romero Arenas MA; Olsen C; Yao JC
J Gastrointest Cancer; 2019 Jun; 50(2):345-348. PubMed ID: 29110229
[No Abstract] [Full Text] [Related]
20. A pregnant patient with hypoglycemia.
Mannelli L; Yeh MM; Wang CL
Gastroenterology; 2012 Oct; 143(4):e3-4. PubMed ID: 22921669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
